0 items USD 0.00Search
Your search for "globaldata axikin pharmaceuticals inc pharmaceuticals healthcare deals alliances profile" gave back 1500434 results.
The global Allergic Asthma Therapeutics market size is expected to reach US$ 8092.3 million by 2029, growing at a CAGR of 2.8% from 2023 to 2029. The...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The global Allergic Asthma Therapeutics market was valued at US$ 6655.8 million in 2023 and is anticipated to reach US$ 8092.3 million by 2030,...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Highlights The global Allergic Asthma Therapeutics market was valued at US$ 6864.7 million in 2022 and is anticipated to reach US$ 8092.3 million by...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
The “Allergic Asthma Therapeutics Industry Forecast” looks at past sales and reviews total world Allergic Asthma Therapeutics sales in 2022,...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Market Analysis and Insights: Global Allergic Asthma Therapeutics Market The global Allergic Asthma Therapeutics market is projected to grow from US...
Catalog:
MRRPB5
March 2023
Price: USD 4,900.00
The global Allergic Asthma Therapeutics market size was valued at US$ 6511 million in 2023. With growing demand in downstream market, the Allergic...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Astex Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Astex Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance...
MarketLine
November 2022
Price: USD 175.00
Rigel Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Rigel Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance...
MarketLine
December 2022
Price: USD 175.00
Achillion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Achillion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate...
MarketLine
February 2020
Price: USD 175.00
BioMarin Pharmaceutical Inc. - Strategy, SWOT and Corporate Finance Report Summary BioMarin Pharmaceutical Inc. - Strategy, SWOT and Corporate...
MarketLine
December 2022
Price: USD 175.00
Sunesis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sunesis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate...
MarketLine
November 2020
Price: USD 175.00
Progenics Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Progenics Pharmaceuticals, Inc. - Strategy, SWOT and Corporate...
MarketLine
January 2021
Price: USD 175.00
Ultragenyx Pharmaceutical Inc. - Strategy, SWOT and Corporate Finance Report Summary Ultragenyx Pharmaceutical Inc. - Strategy, SWOT and Corporate...
MarketLine
January 2023
Price: USD 175.00
Alexion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Alexion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate...
MarketLine
November 2022
Price: USD 175.00
Alexion Pharmaceuticals, Inc - Strategy, SWOT and Corporate Finance Report Summary Alexion Pharmaceuticals, Inc - Strategy, SWOT and Corporate...
MarketLine
November 2021
Price: USD 175.00
